SEC Filing Summary: Prima BioMed Ltd (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Prima BioMed Ltd, a foreign private issuer, on January 7, 2015, with a report date of January 6, 2015. The registrant is headquartered in Sydney, Australia, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
The filing discloses a change in a director's interest, as detailed in Exhibit 99.1 (Appendix 3Y Change of Director's Interest Notice). No other material changes to operations or financial position are described in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to report the change in director interest.
Key Facts for Investor Verification
- Verify the specific details of the director's interest change referenced in Exhibit 99.1.
- Confirm the identity of the director involved in the transaction.
- Review the company's most recent Form 20-F for comprehensive financial data, as this 6-K contains no financial figures.